Clinical Study

Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate Cbp-201 In Adult Patients With Chronic Rhinosinusitis With Nasal Polyps

Posted Date: Nov 19, 2021

  • Investigator: Ahmad Sedaghat
  • Specialties:
  • Type of Study: Drug

To evaluate the efficacy of CBP-201 on a background of mometasone furoate nasal spray (MFNS) in reducing endoscopic nasal polyp score (NPS) and nasal congestion/obstruction score (NCS) severity in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) whose disease remains inadequately controlled despite daily treatment with intranasal corticosteroid (INCS) therapy in comparison to placebo.


Patients Who Are Diagnosed With Chronic Rhinosinusitis With Bilateral Polyps Despite Treatment With Systemic Corticosteroid Within The Past 2 Years


Chronic Rhinosinusitis, Nasal Polyps

For More Information:

Becky Reinert

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.